Table 4.

Results of univariate analyses of utility scores.

Variables	EQ-5D utility				EQ VAS
	Mean	SD	F/t	p-value	Mean	SD	F/t	p-value
All patients (n = 125)	0.53	0.26			48.5	20.98
Sociodemography
Capacity to pay
Not affordable	0.46	0.24			42.89	18.29
Affordable	0.65	0.25	−4.26	<0.0001**	57.18	22.09	−3.93	0.0001**
Life threatening
No	0.79	0.14	3.02		65.88	19.65
Yes	0.51	0.26		0.0031**	47.31	20.62	2.47	0.0148**
Response to treatment
No change/deterioration	0.42	0.28			39.45	18.64
Improvement	0.63	0.20	−4.72	<0.0001**	56.85	19.63	−5.07	<0.0001**
Side effects
Unbearable	0.27	0.3			34.17	19.50
Bearable	0.57	0.23	−4.97	<0.0001**	50.91	20.33	−3.25	0.0015**
Social support
Low support	0.45	0.15			48.75	13.15
Moderate support	0.40	0.32			35.23	17.18
High support	0.60	0.19	10.67	0.0001*	55.79	19.72	16.68	<0.0001*
Psychology factors
Depression
Likely noncase	0.70	0.15			65.74	14.76
Doubtful case	0.52	0.24			45.22	16.41
Likely case	0.31	0.24	31.16	<0.0001*	28.39	12.39	63.30	<0.0001*
Anxiety
Likely noncase	0.72	0.15			67.09	15.77
Doubtful case	0.52	0.20			43.84	15.92
Likely case	0.33	0.27	31.4	<0.0001*	33.13	14.94	51.60	<0.0001*

EQ VAS, EQ-visual analog scale; EQ-5D, EuroQol-5 Dimensions.

*ANOVA test; **t-test.